Contracts › HHSN27500007
HHSN27500007: Igf::Ot::Igf Contraceptive Clinical Trial Network - Male Sites - Contraceptive Efficacy Clinical Trialcontract # HHSN275201300024I/HHSN27500007
Awarded to Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center by National Institutes of Health (NIH).
$12.0Mobligated
$12.0Mpotential value
31 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HHSN27500007 |
|---|---|
| Vehicle | HHSN275201300024I |
| Awardee | Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541711 Research and Development in Biotechnology |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | CA |
| Offers received | 2 |
| Period of performance | 14 September 2015 to 31 December 2026 |
| Potential end | 31 December 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541711 contracts · All expiring contracts · USASpending record